IHI logo

IHIiShares US Medical Devices ETF

$49.80
$0.13
(0.26%)
Pre-Market
Updated: 04:06 AM EDT·Prev Close $49.67
Vol85.00
52W High$64.71
52W Low$47.37
34

Bearish Sentiment

How do you feel about IHI?

News
all
press releases
The Silver Tsunami: Healthcare ETFs to Buy Amid Aging US Demographics
ETFs like XLV stand out as aging U.S. demographics fuel rising demand for healthcare, medical devices and senior-focused care.
Zacks
News Placeholder
More News
News Placeholder
Should You Invest in the iShares U.S. Medical Devices ETF (IHI)?
Sector ETF report for IHI
Zacks
News Placeholder
Buy the Dip in These Top-Ranked ETFs
Market volatility from Iran tensions has created dip-buying chances. Here are 5 ETFs across tech, semis, dividends, healthcare and financials.
Zacks
News Placeholder
Why Did BFLY Stock Surge More Than 23% Pre-Market Today?
The company posted Q4 revenue of $31.5 million, marking a 41% increase year-on-year (YoY), while the adjusted loss per share (EPS) for the quarter was $0.02.
Stocktwits
News Placeholder
Should You Invest in the iShares U.S. Medical Devices ETF (IHI)?
Sector ETF report for IHI
Zacks
News Placeholder
Why Did GUTS Stock Plummet Today Despite Positive Gut Therapy Midterm Study?
Six-month data from 40 participants suggest that Revita helps limit weight regain after GLP-1 discontinuation.
Stocktwits
News Placeholder
Why Did Glucotrack Stock Surge 12% Pre-Market Today?
The company has received patents for its continuous blood glucose monitoring system.
Stocktwits
News Placeholder
INMD Stock Jumped Nearly 13% Today – What’s Powering The Rally?
According to a Calcalist report, the company is set to go private after a $1.1 billion acquisition by a fund.
Stocktwits
News Placeholder
Winners & Losers: The ETF Playbook to Glide Trump's Great Healthcare Plan
Trump's Great Healthcare Plan redraws healthcare winners and losers - here's how ETFs like IHE could benefit as middlemen face pressure.
Zacks
News Placeholder
Retail Traders Are Piling Into TG Therapeutics – What’s Driving The Chatter?
On Tuesday, the company provided the revenue outlook for 2026 and fourth-quarter (Q4) and fiscal year 2025 revenue projection for BRIUMVI.
Stocktwits
<
1
2
...
>

Advertisement|Remove ads.